Join us on January 25, 2022 for insights and guidance on the potential impact of delayed PMPRB Pricing Regulations and Guidelines.

Health Canada’s announcement on December 23, 2021 delayed the coming into force date for the Patented Medicines Regulations by a further six months to July 1, 2022. This is the fourth such delay since the regulations were initially planned to come into force more than a year and a half ago.  For patentees and interested stakeholders, big questions remain unanswered:Will the new guidelines come into force at all?Will only part of the new guidelines come into force?Will the guidelines be scrapped all together?And what does all this mean for current and future patented medicine prices?An expert panel moderated by PDCI’s John-Paul Dowson will dive into these and other questions during an interactive 90-minute session. Leading intellectual property lawyer Eileen McMahon and government affairs expert Bill Dempster will join PDCI pricing experts Neil Palmer and Dylan Lamb-Palmer to provide attendees with insights into the strategic, legal and political issues at stake for Canadians’ access to medicines.  

PDCI Webinar – Impact and Implications of the Delayed Regulations and PMPRB Guidelines  
Tuesday, January 25, 2022  
11:00 a.m. to 12:30 p.m. EST 
CLICK HERE to register! 

This webinar is intended for pharmaceutical manufacturers, industry associations, patient stakeholders and other PDCI clients and partners. Registration requires a valid e-mail address. 

Please contact Mevin Mathew, Manager (Acting) Pricing & Data Analytics at Mevin.Mathew@pdci.ca for any questions or further information.